NCT00520208 2013-02-13
STAR-1
CytRx
Phase 2 Completed
Clinical Trials
3 trialsNCT01018069 2011-07-13
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
Aegera Therapeutics
Phase 2 Terminated
NCT00675870 2008-05-12
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
NuRx Pharmaceuticals, Inc.
Phase 2 Unknown